Latest News for: cell therapy

Edit

International competition highlights health care tech

China.dot.org 03 Apr 2025
Other finalists covered 5D printing and more health-related fields, namely smart nano-optic endoscopy, autologous dendritic cell therapy for type 1 diabetes, and brain-computer interfaces.
Edit

Stem Cell Discovery in Human Retina May Lead to Retinal Degeneration Treatments

The Scientist 03 Apr 2025
Stem cell therapies hold promise for promoting regeneration. Retinal stem cells (RSCs) possess self-renewal capabilities and can continuously generate new cells ... cell types ... Cell & Molecular Biology.
Edit

Global Light Therapy Market to Reach USD 1,586.8 Million by 2034 amidst Rising Adoption in Sports and Healthcare | FMI

Pharmiweb 03 Apr 2025
The global light therapy market is on an upward trajectory, projected to reach USD 1,012.1 million by 2024, and is anticipated to grow at a CAGR of 4.6% from 2024 to 2034, reaching an impressive USD 1,586.8 million by 2034.
Edit

Stem Cell Innovators: 4 Companies Advancing Regenerative Medicine

GetNews 02 Apr 2025
a nutritional supplement business and its medical division, Adia Med, which is focused on advanced stem cell therapies ... CTX112 is a next-generation CAR T-cell therapy for blood cancers and autoimmune diseases.
Edit

Title21 Health Solutions Names Jonathan Wofford Chief Commercial Officer

Pharmiweb 02 Apr 2025
Wofford brings extensive experience in software development and a deep understanding of the cell therapy/stem cell transplant fields as Title21 seeks to expand the reach of its cell and gene therapy ...
Edit

IAH Wellness in Andorra, an advanced immunotherapy clinic specializing in Lyme disease

GetNews 02 Apr 2025
Insulin Potentiated Therapy exploits the “door opening” function of insulin in the cell membranes, allowing the necessary substances to be introduced into the organism and attack the ...
Edit

Japan’s pioneering stem cell treatment enables paralyzed man to stand again

The Times of India 02 Apr 2025
This means only the beginning, but the results provide a vision of a time when stem cell therapies might return lost function following spinal injury and improve the health of paralysis victims.
Edit

Follicular Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Roche, ...

GetNews 02 Apr 2025
... refractory FL and large B-cell lymphomas, including diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, and primary mediastinal large B-cell lymphoma, after two or more prior therapies.
Edit

VORTEX ANNOUNCES CLINICAL STUDY WITH UNIVERSITY OF MARYLAND BALTIMORE

Pharmiweb 02 Apr 2025
Together, we are providing a unique perspective on these cells, which has the potential to accelerate the development of a new generation of oncological therapies and further strengthen the commercialisation of our technology.
Edit

Israeli Researchers Develop scNET to Enhance Drug and Disease Research

Famagusta Gazette 02 Apr 2025
Researchers emphasized its potential to decode complex cell behavior and aid in designing targeted therapies.
Edit

Systemic Sclerosis Market on Track for Major Expansion by 2034, According to DelveInsight | Kyowa ...

GetNews 02 Apr 2025
(Kyverna), a clinical-stage biopharmaceutical company dedicated to developing cell therapies for autoimmune disease patients, announced today the publication in Med1 of a report detailing the first ...
Edit

Struggling with severe or chronic pain? This novel therapy may be the answer

South China Morning Post 02 Apr 2025
When Tim Noonan’s shoulder tore in 2014, stem cell therapy eased his extreme pain – 10 years later, he returns for more of the novel therapy ... .
Edit

Novadip appoints Soumya Chandramouli as Chief Financial Officer

Pharmiweb 02 Apr 2025
NVD003, an autologous cell-based therapy currently in phase 1b/2a clinical trials in adults with bone nonunion, and pediatric congenital pseudarthrosis of the tibia; and NVDX3, an allogenic bone ...
×